ORMP icon

Oramed Pharmaceuticals

88 hedge funds and large institutions have $29.6M invested in Oramed Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

41% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 34

62% less capital invested

Capital invested by funds: $78.4M → $29.6M (-$48.7M)

Holders
88
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$854K
Puts
$228K
Net Calls
Net Calls Change

Top Buyers

1 +$2.12M
2 +$1.65M
3 +$1.46M
4
E
Ergoteles
New York
+$1.03M
5
Millennium Management
Millennium Management
New York
+$993K

Top Sellers

1 -$7.75M
2 -$3.33M
3 -$2.92M
4
State Street
State Street
Massachusetts
-$2.25M
5
Nuveen Asset Management
Nuveen Asset Management
Illinois
-$1.46M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$213K
27
$211K
28
$186K
29
$182K
30
$171K
31
$135K
32
$130K
33
$122K
34
$106K
35
$97K
36
$96K
37
$93K
38
$92K
39
$92K
40
$90K
41
$90K
42
$89K
43
$88K
44
$83K
45
$83K
46
$79K
47
$62K
48
$61K
49
$57K
50
$53K